New research suggests that blood tests known as “liquid biopsies” can improve the treatment of some people with metastatic ...

Bristol Myers Squibb is partnering with BioNTech on a closely watched cancer drug, in a deal worth billions of dollars.

A clinical trial found that women could switch drugs without waiting for scans showing cancer progression, which improved ...

New targeted therapies allow for the treatment of a disease that is already the fifth leading cause of fatal tumors globally ...

Bristol-Myers Squibb Co. will pay BioNTech SE as much as $11.1 billion to license a next-generation cancer drug, as ...

Diagnosed with early-stage lung cancer, she is among the first patients in China to receive the LK101 injection – a personalised mRNA vaccine designed to slash the risk of relapse. Lecheng ...

Data presented at ASCO show that swapping in the oral drug camizestrant for an older therapy helped sustain the benefit of ...

A large prospective, randomized clinical trial in patients with advanced breast cancer has found that the use of liquid biopsy blood tests for early ...

Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first sign of resistance to standard ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall ...

An experimental treatment by Pfizer and Arvinas delayed progression of breast cancer by more than three months compared to ...

Treating breast cancer patients with AstraZeneca's experimental pill camizestrant at the first sign of resistance to standard ...